119 related articles for article (PubMed ID: 17312098)
1. Human tumor immunology at the molecular divide.
Finn OJ
J Immunol; 2007 Mar; 178(5):2615-6. PubMed ID: 17312098
[No Abstract] [Full Text] [Related]
2. Tumor immunology: Paul Ehrlich's heritage.
Johnson JP; Riethmüller G; Schirrmacher V
Immunol Today; 1989 Aug; 10(8):S35-7. PubMed ID: 2679644
[No Abstract] [Full Text] [Related]
3. Unique human tumor antigens: immunobiology and use in clinical trials.
Parmiani G; De Filippo A; Novellino L; Castelli C
J Immunol; 2007 Feb; 178(4):1975-9. PubMed ID: 17277099
[TBL] [Abstract][Full Text] [Related]
4. Tumor immunology.
Stevenson H; Tsang KY
Immunol Ser; 1993; 58():497-515. PubMed ID: 8424991
[No Abstract] [Full Text] [Related]
5. Milestones in tumor immunology.
Bartlett GL
Semin Oncol; 1979 Dec; 6(4):515-25. PubMed ID: 394333
[No Abstract] [Full Text] [Related]
6. Recognition of tumor-associated antigens by T lymphocytes: from basic concepts to new approaches.
Cerottini JC; von Fliedner V; Boon T
Ann Oncol; 1992 Jan; 3(1):11-6. PubMed ID: 1606063
[No Abstract] [Full Text] [Related]
7. Genomic prediction of neoantigens: immunogenomics before NGS.
Mardis ER
Nat Rev Genet; 2021 Sep; 22(9):550-551. PubMed ID: 33990775
[No Abstract] [Full Text] [Related]
8. Cancer is a somatic cell pregnancy.
Old LJ
Cancer Immun; 2007 Nov; 7():19. PubMed ID: 17983204
[No Abstract] [Full Text] [Related]
9. Immunotherapy exposes cancer stem cell resistance and a new synthetic lethality.
Radvanyi L
Mol Ther; 2013 Aug; 21(8):1472-4. PubMed ID: 23903573
[No Abstract] [Full Text] [Related]
10. New paths in human cancer serology.
Old LJ; Chen YT
J Exp Med; 1998 Apr; 187(8):1163-7. PubMed ID: 9547328
[No Abstract] [Full Text] [Related]
11. Tumor-specific antigen of murine T-lymphoma defined with monoclonal antibody. 1982.
Allison JP; McIntyre BW; Bloch D
J Immunol; 2005 Feb; 174(3):1144-51. PubMed ID: 15661866
[No Abstract] [Full Text] [Related]
12. Scientific contributions toward successful cancer immunotherapy in The Netherlands.
Melief CJ; Scheper RJ; de Vries IJ
Immunol Lett; 2014 Dec; 162(2 Pt B):121-6. PubMed ID: 25455598
[TBL] [Abstract][Full Text] [Related]
13. Tumor-specific T-cell immunity: ready for prime time?
Greenberg PD; Riddell SR
J Natl Cancer Inst; 1992 Jul; 84(14):1059-61. PubMed ID: 1619675
[No Abstract] [Full Text] [Related]
14. [RNA-loaded dendritic cells].
Hinoda Y
Nihon Rinsho; 2005 Apr; 63 Suppl 4():613-8. PubMed ID: 15861719
[No Abstract] [Full Text] [Related]
15. Principles of tumor immunology.
Den Otter W
Postepy Hig Med Dosw; 1988; 42(2):117-24. PubMed ID: 3075997
[No Abstract] [Full Text] [Related]
16. Cancer genetics and tumor antigens: time for a combined view?
Meese E; Comtesse N
Genes Chromosomes Cancer; 2002 Feb; 33(2):107-13. PubMed ID: 11793436
[No Abstract] [Full Text] [Related]
17. Calling cancer's bluff with neoantigen vaccines.
DeWeerdt S
Nature; 2017 Dec; 552(7685):S76-S77. PubMed ID: 29293229
[No Abstract] [Full Text] [Related]
18. Tumor-specific antigens and immunologic adjuvants in cancer immunotherapy.
Seremet T; Brasseur F; Coulie PG
Cancer J; 2011; 17(5):325-30. PubMed ID: 21952282
[TBL] [Abstract][Full Text] [Related]
19. Human tumor antigens recognized by T lymphocytes.
Boon T; van der Bruggen P
J Exp Med; 1996 Mar; 183(3):725-9. PubMed ID: 8642276
[No Abstract] [Full Text] [Related]
20. [Cancer immunotherapy targeting neoantigens derived from tumor-specific gene mutations].
Sasada T
Nihon Rinsho; 2017 Feb; 75(2):189-195. PubMed ID: 30562851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
